BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951
48 results:

  • 1. Mobile Phone Use and Risks of Overall and 25 Site-Specific Cancers: A Prospective Study from the UK Biobank Study.
    Zhang Y; Zhang Y; Ye Z; Yang S; Liu M; Wu Q; Zhou C; He P; Gan X; Qin X
    Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):88-95. PubMed ID: 37870426
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation.
    Lehrer R; Cornelis F; Bernhard JC; Bigot P; Champy C; Bruyère F; Rouprêt M; Doumerc N; Bensalah CK; Olivier J; Audenet F; Tricard T; Parier B; Durand X; Durand M; Charles T; Branger N; Surlemont L; Xylinas E; Beauval JB; Barral M
    Eur Radiol; 2023 Dec; 33(12):8426-8435. PubMed ID: 37466710
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The impact of body mass index on oncological and surgical outcomes of patients undergoing nephrectomy: a systematic review and meta-analysis.
    Ong CSH; Law TYX; Mok A; Ho KSC; Wang Z; Chiong E; Tiong HY; Teoh JYC
    BJU Int; 2023 Dec; 132(6):608-618. PubMed ID: 37401806
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Estimating the Effectiveness of kidney Cancer Screening Within Lung Cancer Screening Programmes: A Validation in UK Biobank.
    Harrison H; Wood A; Pennells L; Rossi SH; Callister M; Cartledge J; Stewart GD; Usher-Smith JA
    Eur Urol Oncol; 2023 Jun; 6(3):351-353. PubMed ID: 37003861
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CT-based preoperative risk assessment of prolonged urine leak in patients undergoing partial nephrectomy.
    Lee HJ; Kim SY; Cho JY; Kim TM
    Eur Radiol; 2023 Jun; 33(6):3801-3809. PubMed ID: 36565351
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive Factors for Acute kidney Injury and Long-Term Renal Function Loss After Partial Nephrectomy: A Prospective Single-Center Study.
    Zhang S; He M; Li Y; Xu P; Huang J; Guo J; Wang H
    Urology; 2023 Feb; 172():138-143. PubMed ID: 36436674
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association between secondhand smoke and cancers in adults in the US population.
    Zhang Z; Li Z; Zhang X; Ye W; Chen J; Wang L; Lin Z; Li J; Li Z
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3447-3455. PubMed ID: 35943599
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma.
    Zhanghuang C; Wang J; Yao Z; Li L; Xie Y; Tang H; Zhang K; Wu C; Yang Z; Yan B
    Front Public Health; 2022; 10():874427. PubMed ID: 35444972
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Management of metastatic renal cell carcinoma following prior vascular endothelial growth factor-targeted therapy: A real-world retrospective study from Taiwan.
    Chung HJ; Chang YH; Huang YH; Lin TP; Wei TC; Lin FJ; Huang HH; Wang HC
    J Chin Med Assoc; 2022 Apr; 85(4):438-442. PubMed ID: 35125401
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective.
    Engel Ayer Botrel T; Datz Abadi M; Chabrol Haas L; da Veiga CRP; de Vasconcelos Ferreira D; Jardim DL
    J Med Econ; 2021; 24(1):291-298. PubMed ID: 33538203
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Ryoo H; Kim J; Kim T; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Cancer Res Treat; 2021 Jul; 53(3):795-802. PubMed ID: 33421984
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015.
    Scott AR; Stoltzfus KC; Tchelebi LT; Trifiletti DM; Lehrer EJ; Rao P; Bleyer A; Zaorsky NG
    JAMA Netw Open; 2020 Dec; 3(12):e2027738. PubMed ID: 33258907
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Temporal trends in loss of life expectancy after a cancer diagnosis among the Australian population.
    Kou K; Dasgupta P; Cramb SM; Yu XQ; Andersson TM; Baade PD
    Cancer Epidemiol; 2020 Apr; 65():101686. PubMed ID: 32062407
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Mori K; Janisch F; Parizi MK; Mostafaei H; Lysenko I; Kimura S; Enikeev DV; Egawa S; Shariat SF
    J Urol; 2020 Jun; 203(6):1075-1084. PubMed ID: 31479406
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Adjuvant Therapy in High-Risk Renal Cell Cancer: A Systematic Review and Meta-analysis.
    Riaz IB; Faridi W; Husnain M; Malik SU; Sipra QUAR; Gondal FR; Xie H; Yadav S; Kohli M
    Mayo Clin Proc; 2019 Aug; 94(8):1524-1534. PubMed ID: 31303430
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Examining Public Communication About kidney Cancer on Twitter.
    Sedrak MS; Salgia MM; Decat Bergerot C; Ashing-Giwa K; Cotta BN; Adashek JJ; Dizman N; Wong AR; Pal SK; Bergerot PG
    JCO Clin Cancer Inform; 2019 Mar; 3():1-6. PubMed ID: 30860867
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Influence of segmentation margin on machine learning-based high-dimensional quantitative CT texture analysis: a reproducibility study on renal clear cell carcinomas.
    Kocak B; Ates E; Durmaz ES; Ulusan MB; Kilickesmez O
    Eur Radiol; 2019 Sep; 29(9):4765-4775. PubMed ID: 30747300
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
    Iwata T; Kimura S; Foerster B; Abufaraj M; Karakiewicz PI; Preisser F; Nasu Y; Shariat SF
    Urol Oncol; 2019 Apr; 37(4):273-281. PubMed ID: 30737159
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study.
    Bamias A; Karavasilis V; Gavalas N; Tzannis K; Samantas E; Aravantinos G; Koutras A; Gkerzelis I; Kostouros E; Koutsoukos K; Zagouri F; Fountzilas G; Dimopoulos MA
    Int J Clin Oncol; 2019 Apr; 24(4):411-419. PubMed ID: 30374686
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study.
    White VM; Marco DJT; Bolton D; Papa N; Neale RE; Coory M; Davis ID; Wood S; Giles GG; Jordan SJ
    BJU Int; 2018 Nov; 122 Suppl 5():50-61. PubMed ID: 30307688
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.